News Announcements

ADM Tronics Unlimited Inc.

OneMed Research Initiates Coverage of ADM Tronics.
5/8/2017

remeron

remeron

sertraline tablets 50mg

sertraline 50mg side effects read here
NORTHVALE, N.J., May 8, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) announced today that OneMed Research (a division of OneMedMarket) has initiated research coverage of ADM Tronics. OneMedMarket specializes in the healthcare industry.

OneMedMarket is a New York-based life science and healthcare research and investor communications firm providing business development services to emerging growth companies and identifying investment opportunities for healthcare investors.

Brett Johnson, Founder and CEO of OneMedMarket commented, "ADMT is a serious company with an arsenal of innovative and proprietary technologies positioned to make a quantum leap into the major healthcare arena. Having designed some of the most sophisticated medical devices for cutting edge companies, ADMT has leveraged its expertise to develop its digital therapeutic and diagnostic medical device technologies that can impact greater efficacy and compliance."

Mr. Johnson continued, "We discovered ADMT during our recent focus on studying alternative treatments for chronic pain as a substitute for opiates. Electronic Therapy is currently garnering increased attention as the opiate addiction crisis increases throughout the country. This truly is a company with numerous technologies which could potentially help shape the future of health and medicine in the US and abroad."

Andre' DiMino, CEO of ADMT, remarked, "We are pleased and excited to get analyst coverage by an organization with the combination of healthcare industry knowledge, skills and tools necessary to advance our efforts and create awareness of ADM Tronics' growth potential."

About OneMed Research
OneMed Research group specializes in finding the most promising emerging growth companies in the healthcare market with the objective of bringing healthcare investors and analysts together with healthcare technology companies that demonstrate exceptional growth potential within each company's particular area of expertise.

Conferences. OneMedForum showcases promising companies at conferences which include, San Francisco, New York, Shanghai and other large cities.

Research. OneMedResearch provides research on investment opportunities in private and public companies in various healthcare sectors.

Investment Search. The company offers investment search services to investors seeking insight on emerging companies and breakthrough technologies.

Media. OneMedMedia provides communications services to companies via the OneMed Sentinel, OneMedNews, OneMedTV and OneMedRadio.

Liquidity. OneMedMarket is currently working towards providing liquidity for shareholders of both public and private healthcare and life science companies.

About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Medical Device Design, Engineering, Regulatory and Manufacturing Services; Proprietary Electronic Medical Devices; and Eco-Friendly, Water-Based Formulations. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D prototyping, precision instrumentation and specialized software and peripherals, for the research, development and commercialization of diversified technologies. Additional information is available at the Company's websites - admtronics.com and concepttoquantity.com.

Except for historical information contained herein, the matters set forth in this news release are "forward looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.

OneMed Research Initiates Coverage of ADM Tronics